[EN] IMIDAZOLE DERIVATIVES AS IDO INHIBITORS<br/>[FR] DÉRIVÉS IMIDAZOLE COMME INHIBITEURS DE L'IDO
申请人:NEWLINK GENETICS
公开号:WO2011056652A1
公开(公告)日:2011-05-12
Presently provided are IDO inhibitors of general formulae (VII), (VIII) as shown below and pharmaceutical compositions thereof, useful for modulating an activity of indoleamine 2,3-dioxygenase; treating indoleamine 2,3-dioxygenase (IDO) mediated immunosuppression; treating a medical conditions that benefit from the inhibition of enzymatic activity of indoleamine-2,3-dioxygenase; enhancing the effectiveness of an anti-cancer treatment comprising administering an anti-cancer agent; treating tumor-specific immunosuppression associated with cancer; and treating immunosupression associated with an infectious disease.
目前提供的是通用结构式(VII)、(VIII)所示的IDO抑制剂及其药物组合物,用于调节色胺酸2,3-二氧化酶的活性;治疗色胺酸2,3-二氧化酶(IDO)介导的免疫抑制;治疗受益于色胺酸-2,3-二氧化酶酶活性抑制的医疗状况;增强包括给予抗癌药物在内的抗癌治疗的有效性;治疗与癌症相关的肿瘤特异性免疫抑制;以及治疗与传染性疾病相关的免疫抑制。